ORBIMED ADVISORS LLC 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-08 4:34 pm Sale | 2024-03-06 | 13D | NextCure, Inc. NXTC | ORBIMED ADVISORS LLC | 105,668 4.500% | -120,250 (-53.23%) | Filing |